Artisan Bio to present cell therapies designed by CRISPR at Meeting on the Mesa
DENVER, October 11, 2021 / PRNewswire / – Artisan Bio, Inc. to Showcase its STAR Platform Used for Precision Cell Engineering at Cell & Gene 2021 Meeting on the Mesa on 12 October 2021 in Carlsbad, California. Ryan t gill, PhD, CEO of Artisan Bio, will provide insight into the company’s technology platform and data from partnered collaborations. Artisan’s STAR platform provides a fully integrated approach and new route to commercialization for CRISPR-engineered cell therapies, which has now been demonstrated in work with several biopharmaceutical collaborators.
The Cell & Gene Meeting on the Mesa brings together leading researchers, leaders and decision-makers to advance cutting-edge research into the most recent therapy of tomorrow. “The Mesa Meeting provides Artisan with an exciting venue to share our latest and cutting edge successes with the STAR platform, which is at the heart of Artisan’s precision cell engineering technology. “Said Dr Gill. “We will highlight some of the technical achievements by describing how Artisan is revolutionizing the way high-value cell therapy candidates are developed. “
Artisan Bio’s STAR platform combines high throughput workflows and sophisticated data analysis with a proprietary family of novel endonuclease-based editing systems to produce high-value candidate cell therapy designs. The STAR platform has been validated with T cells, induced pluripotent stem cells (iPSC), several primary cell types and cancer cells, in addition to industrial cell lines like CHO and HEK293.
Artisan’s STAR platform is embedded in the world’s first dedicated immune cell foundry, which enables rapid identification of high-quality candidate cell designs through a proprietary cell engineering and high-throughput screening workflow that covers the main genotypic and phenotypic tests. “Artisan’s process for moving from a design cell therapy to a high value candidate allows for the evaluation of a much higher number of possible candidate designs, leading to the identification of superior configurations in a similar fashion. how the selection of antibody candidates works, ”explains Dr. Gill. “Our approach can lead to more efficient candidates compared to more traditional development processes.”
Artisan Bio, Inc.
Artisan’s vision is to design, build and deliver precision engineered cells and processes that advance cell therapies in a wide range of human health indications. The company’s design cell engineering and development platform enables partners to more efficiently optimize candidate designs and thereby generate safer and more effective cell therapies. By engaging in strategic collaborations with innovative partners, Artisan seeks to provide customizable cell engineering solutions that address the complexities associated with next generation cell therapies. Artisan has offices at Denver, Colorado and Toronto, Canada. For more information, please visit http://artisancells.com/.
Media contact: Tanya warnecke [email protected]
SOURCE Organic Artisan